ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Gossamer Bio, Inc. (GOSS)

NASDAQ

$2.31

$-0.01

(-0.43%)

Gossamer Bio, Inc. (GOSS) Live Price Chart

Page last updated: 2026-02-13 20:40:09

Key Market Data

Market Cap	$533.51M
Open	$2.34
High	$27.15
Low	$0.45
Previous Close	$2.32
Price Change	$-0.01
Percentage Change	-0.43%
Volume	4M

Gossamer Bio, Inc. (GOSS) Stock Price Today

Gossamer Bio, Inc. (GOSS) is currently trading at $2.31 as of 2026-02-13 20:40:09, reflecting a -0.43% move ($-0.01) from the previous close.

In the short term, the stock has returned -591.84% over the past four weeks. Over the last 12 months, Gossamer Bio, Inc. has recorded a +75.95% price change, indicating a strong performance relative to the broader market.

Gossamer Bio, Inc. (GOSS) 7-Day Stock Price Changes

Over the past seven days, Gossamer Bio, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $2.27 to the latest recorded price of $2.31, reflecting an intraday change of -0.43%. Daily movements highlight shifts in trading volume (4,190,071), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, GOSS has delivered a -591.84% return over the past month and a +75.95% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Gossamer Bio, Inc. (GOSS)

You can buy and trade GOSS on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for GOSS and Execute Your Trade

Open the trading page, enter GOSS in the search bar, select the amount of GOSS you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Gossamer Bio, Inc. (GOSS)?

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	145
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.gossamerbio.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Gossamer Bio, Inc.?

The latest trading price for Gossamer Bio, Inc. (Common Stock) is $ 2.31, compared with a previous closing price of $ 2.32. That means the stock has moved -0.43% so far today. Intraday price updates and recent trading activity for GOSS can be tracked on the live chart and quote section on this page.

2.Is Gossamer Bio, Inc. stock going up or down?

Looking at recent performances, GOSS has returned -591.84% over the past month, +15.83% over the last six months and +75.95% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Gossamer Bio, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does GOSS currently sit relative to its 52-week high and low?

In the most recent 52-week period, Gossamer Bio, Inc. has traded between a low of $ 0.76 and a high of $ 3.87. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether GOSS is currently nearer the top or the bottom of its one-year trading band.

4.How is Gossamer Bio, Inc. classified by sector and industry?

Gossamer Bio, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means Gossamer Bio, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing GOSS’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence Gossamer Bio, Inc.’s performance.

5.Where is Gossamer Bio, Inc. listed and how large is it by market value?

Gossamer Bio, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 533.51M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Gossamer Bio, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does GOSS's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.67 summarises how much profit Gossamer Bio, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Gossamer Bio, Inc.'s financial performance over time?

To follow Gossamer Bio, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how GOSS is performing and how the market is responding.

8.When is Gossamer Bio, Inc. expected to report earnings?

Gossamer Bio, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for GOSS, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Gossamer Bio, Inc.'s earnings reports?

Gossamer Bio, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether GOSS is meeting, beating or missing expectations.

10.How can I stay informed about Gossamer Bio, Inc.'s results and guidance?

You can stay up to date on Gossamer Bio, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for GOSS on this page helps you see how new information is being reflected in the stock.

11.Does Gossamer Bio, Inc. pay a regular cash dividend to its shareholders?

Gossamer Bio, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor GOSS's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for GOSS?

Based on the latest earnings data, GOSS has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Gossamer Bio, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Gossamer Bio, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Gossamer Bio, Inc.?

Gossamer Bio, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is GOSS valued in terms of P/E ratio and EPS?

Gossamer Bio, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.67. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Gossamer Bio, Inc.'s earnings. Comparing GOSS's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Gossamer Bio, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Acco Brands Corporation

ACCO

Enova International, Inc.

ENVA

EMPIRE STATE REALTY TRUST, INC.

ESRT

Howard Hughes Holdings Inc.

HHH

Sweetgreen, Inc.

Top Gainers

Browse today's leading gainers in the US stock market

Founder Group Limited

FGL

JIADE LIMITED

JDZG

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

MYX

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

GOSS-to-USD Calculator

Amount

GOSS

USD

1 GOSS = 2.305 USD